US FDA approves revakinagene taroretcel-lwey (ENCELTO) for macular telangiectasia type 2
The encapsulated cell therapy from Neurotech Pharmaceuticals is the first FDA-approved treatment for MacTel
PHOTON Results and Their Relation to DME Patients in Your Practice
John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.
Enhancing the Patient Journey Solutions for Streamlining Success in Cataract Surgery
PULSAR Results and Their Relation to nAMD Patients in Your Practice
John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.
Enhancing the Patient Journey Solutions for Effective GA Management
Enhancing the Patient Journey: Solutions for Effective GA Management
